Pricing Log in Create free account
Friday 6 November 2026 Export GSK’s income statement to Excel — free account

GSK PLC Sponsored ADR

GSK Healthcare Drug Manufacturers General

GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024.

Revenue
+3.75%
EPS
−14.7%
Free cash flow
+62.4%
Total debt
+33.2%

Quarter to September 2026, against a year earlier

50.43 0.02 +0.04%
Market cap
$101.0B
P/E
16.7×
Fwd P/E
14.6×
Dividend yield
3.60%
F-score
9/9
Altman Z
2.12
Beneish M
−2.46
Dividend safety
54/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

GSK PLC Sponsored ADR (GSK) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, GSK PLC Sponsored ADR (GSK) trades at a price to free cash flow of 11.4×. Over the past ten years it has ranged from 0.0× (June 2016) to 42.2× (February 2016); the current reading is higher than 29% of that period. That is below the Drug Manufacturers General industry median of 21.3× and below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 15.4× 7.48%
FY2024 14.3× 4.62%
FY2023 13.7× 30.75%
FY2022 10.5× (22.56%)
FY2021 13.5× 42.64%
FY2020 9.5× (33.83%)
FY2019 14.3× 43.54%
FY2018 10.0× (28.09%)
FY2017 13.9× (9.95%)
FY2016 15.4× (61.95%)

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 10.9× (20.51%)
Jun 2026 13.8× (18.95%)
Mar 2026 17.0× 10.30%
Dec 2025 15.4× 13.85%
43 more quarters

Against its own ten years

Low 0.0× High 42.2×
Ten-year median 13.5×
Current reading's percentile 29

Price to free cash flow against peers

Company Price to free cash flow
SNY Sanofi compare 6.7×
GSK GSK PLC Sponsored ADR 11.4×
BMY Bristol Myers Squibb Company compare 13.9×
GILD Gilead Sciences, Inc. compare 15.1×
PFE Pfizer Inc. compare 15.5×
BIIB Biogen Inc. compare 21.3×
NVO Novo Nordisk A/S compare 23.5×
AMGN Amgen Inc. compare 27.3×
AZN AstraZeneca PLC compare 45.8×
Drug Manufacturers General industry median 21.3×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on GSK